Join
Live feed
·
PRReleasevia Quantisnow
Better Therapeutics Inc. logo

Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BTTX (Better Therapeutics Inc.) and more on Quantisnow.